Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


1 Blood
1 Cancer Res
2 Haematologica
1 Lancet Oncol
10 Leuk Lymphoma
1 Leukemia

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles


  1. MATSUE K, Abe Y, Kitadate A, Miura D, et al
    Sensitivity and specificity of incisional random skin biopsy for diagnosis of intravascular large B-cell lymphoma.
    Blood. 2019 Jan 15. pii: blood-2018-11-887570. doi: 10.1182/blood-2018-11-887570
    PubMed     Text format    

    Cancer Res

  2. TAYLOR A, Rothstein D, Rudd CE
    Small-Molecule Inhibition of PD-1 Transcription Is an Effective Alternative to Antibody Blockade in Cancer Therapy.
    Cancer Res. 2018;78:706-717.
    PubMed     Text format     Abstract available


  3. QDAISAT A, Al Soud R, Wu CC, Rojas Hernandez CM, et al
    Poor performance of D-Dimer in excluding venous thromboembolism among patients with lymphoma and leukemia.
    Haematologica. 2019 Jan 10. pii: haematol.2018.211466.
    PubMed     Text format    

  4. TAKEUCHI M, Miyoshi H, Asano N, Yoshida N, et al
    Human leukocyte antigen class II expression is a good prognostic factor of adult T-cell leukemia/lymphoma.
    Haematologica. 2019 Jan 10. pii: haematol.2018.205567.
    PubMed     Text format     Abstract available

    Lancet Oncol

  5. BROMBERG JEC, Issa S, Bakunina K, Minnema MC, et al
    Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study.
    Lancet Oncol. 2019 Jan 7. pii: S1470-2045(18)30747.
    PubMed     Text format     Abstract available

    Leuk Lymphoma

  6. BOHN JP, Willenbacher W, Haas G, Peschel I, et al
    Pomalidomide in primary intraocular lymphoma.
    Leuk Lymphoma. 2019 Jan 11:1-3. doi: 10.1080/10428194.2018.1538508.
    PubMed     Text format    

  7. RITTER AJ, Goldstein JS, Ayers AA, Flowers CR, et al
    Rural and urban patients with diffuse large B-cell and follicular lymphoma experience reduced overall survival: a National Cancer DataBase study.
    Leuk Lymphoma. 2019 Jan 11:1-12. doi: 10.1080/10428194.2018.1546855.
    PubMed     Text format     Abstract available

  8. JANIGA J, Kentley J, Nabhan C, Abdulla F, et al
    Current systemic therapeutic options for advanced mycosis fungoides and Sezary syndrome.
    Leuk Lymphoma. 2018;59:562-577.
    PubMed     Text format     Abstract available

  9. FRICK M, Bettstetter M, Bertz S, Schwarz-Furlan S, et al
    Mutational frequencies of CD79B and MYD88 vary greatly between primary testicular DLBCL and gastrointestinal DLBCL.
    Leuk Lymphoma. 2018;59:1260-1263.
    PubMed     Text format    

  10. GUZAUSKAS GF, Masaquel A, Thuresson PO, Dawson K, et al
    Obinutuzumab plus chemotherapy followed by obinutuzumab monotherapy is cost-effective vs. rituximab plus chemotherapy followed by rituximab monotherapy for previously untreated follicular lymphoma patients in the United States.
    Leuk Lymphoma. 2019 Jan 11:1-9. doi: 10.1080/10428194.2018.1551532.
    PubMed     Text format     Abstract available

    Immunophenotype switching in cutaneous T-cell lymphoma: nature or nurture?
    Leuk Lymphoma. 2019 Jan 11:1-2. doi: 10.1080/10428194.2018.1543887.
    PubMed     Text format    

  12. CHEN SH, Chen JS, Jou ST, Wu KH, et al
    Outcome and prognosis of anaplastic large cell lymphoma in children: a report from the Taiwan Pediatric Oncology Group.
    Leuk Lymphoma. 2019 Jan 15:1-8. doi: 10.1080/10428194.2018.1562182.
    PubMed     Text format     Abstract available

  13. WANG XX, Li PF, Bai B, Gao Y, et al
    Differential clinical significance of pre-, interim-, and post-treatment plasma Epstein-Barr virus DNA load in NK/T-cell lymphoma treated with P-GEMOX protocol.
    Leuk Lymphoma. 2019 Jan 16:1-9. doi: 10.1080/10428194.2018.1563690.
    PubMed     Text format     Abstract available

  14. PATHAK P, Perimbeti S, Ames A, Moskowitz AJ, et al
    Guillain Barre syndrome heralding the diagnosis of angioimmunoblastic T-cell lymphoma.
    Leuk Lymphoma. 2019 Jan 16:1-4. doi: 10.1080/10428194.2018.1553299.
    PubMed     Text format    

  15. NEVEL KS, Pentsova E, Daras M
    Clinical presentation, treatment, and outcomes of patients with central nervous system involvement in extranodal natural killer/T-cell lymphoma.
    Leuk Lymphoma. 2019 Jan 16:1-8. doi: 10.1080/10428194.2018.1551541.
    PubMed     Text format     Abstract available


  16. DODERO A, Guidetti A, Tucci A, Barretta F, et al
    Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma.
    Leukemia. 2019 Jan 10. pii: 10.1038/s41375-018-0320.
    PubMed     Text format    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.